… Given the low frequency of PBRM1 and BAP1 loss in tumors, a large series was required
to characterize this interaction. In our series of greater than 1,000 patients we identified 23 …

Background Loss-of-function mutations in GRN cause frontotemporal lobar degeneration (FTLD).
Patients with GRN mutations present with a uniform subtype of TAR DNA-binding …

BACKGROUND The majority of patients diagnosed with clear cell renal cell carcinoma (ccRCC)
have low‐risk disease with a < 10% chance of ccRCC‐specific death. DNA sequencing …

Introduction Comparative transcriptome analyses in Alzheimer's disease (AD) and other
neurodegenerative proteinopathies can uncover both shared and distinct disease pathways. …

Folate receptor alpha (FOLR1) has been identified as a potential prognostic and therapeutic
target in a number of cancers. A correlation has been shown between intense …

10.7554/eLife.33480.001 Anthracycline-induced cardiotoxicity (ACT) is a key limiting factor
in setting optimal chemotherapy regimes, with almost half of patients expected to develop …

We performed a meta-analysis of 3 genome-wide association studies to identify additional
common variants influencing chronic lymphocytic leukemia (CLL) risk. The discovery phase …

PURPOSE Recent trials have shown potential benefit of extended adjuvant endocrine therapy
and relatively high risk of recurrence (RoR) after 5 years in hormone receptor-positive (HR…

Background Mammographic breast density is a strong breast cancer risk factor but is not
used in the clinical setting, partly because of a lack of standardization and automation. We …

Background Intratumor molecular heterogeneity has been reported for primary clear cell renal
cell carcinoma (ccRCC) tumors; however, heterogeneity in metastatic ccRCC tumors has …